<!DOCTYPE html>
<html lang="en">
    <head>
        <meta name="DC.IDENTIFIER" content="http://dx.doi.org/10.17917/GS4C-N171" scheme="DCTERMS.UI"><title>caNanoLab DOI Landing page</title>
        <style>
            h1 { text-align: center;}
            h2 { text-align: left;}
            table { border: 1px solid #dddddd; text-align: left; padding: 8px }
            td, th { border: 1px solid #dddddd; text-align: left; padding: 8px }
            tr:nth-child(even) { background-color: #dddddd }
        </style>
    </head><body><img src="./assets/images/crdc-logo.svg" alt="CRDC General Commons Logo"><h1> caNanoLab DOI </h1><hr><p><b>Protocol Type:</b> in vitro assay</p><p><b>Protocol Name:</b> NCL Method IEA-1: Analysis of Nanoparticle Effects on Invasion of Cancer Cells</p><p><b>Protocol Abbreviation:</b> IEA-1</p><p><b>Protocol Version:</b> 1<hr><p><b>DOI:</b> <a href = http://dx.doi.org/10.17917/GS4C-N171>http://dx.doi.org/10.17917/GS4C-N171</a></p><p><b>Protocol File:</b> protocols/20240410_18-11-40-738_NCL_Method_IEA-1.pdf<p><b>File Title:</b> IEA-1</p><p><b>Description:</b></b> This document provides a protocol for a real-time, quantitative assessment of nanoparticle-mediated inhibition of cancer cell invasion. This assay uses human breast cancer cells, MDA-MB-231, as a model cell line. The cells are separated from control chemoattractant and test-nanoparticles by an 8 um filter and an extracellular matrix. The cell migration through the filter is then monitored using a label-free technology developed by ACEA Biosciences, wherein cell attachment to gold electrodes on the underside of the filter results in a change in the impedance. This is subsequently converted into the cell index, which is proportional to the number of cells migrated through the filter.<hr><p><b>Resource Type:</b>  Protocol</p><p><b>Data Access:</b> <a href =https://general.datacommons.cancer.gov/#/data>https://general.datacommons.cancer.gov/#/data</a><p></body></html>